CAMP4 THERAPEUTICS CORPORATION (CAMP) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About CAMP4 THERAPEUTICS CORPORATION
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company…
Source: Yahoo Finance
Sector & Industry
CAMP4 THERAPEUTICS CORPORATION operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
CAMP4 THERAPEUTICS CORPORATION at a Glance
| Company | CAMP4 THERAPEUTICS CORPORATION |
| Ticker | CAMP |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $4.41 |
| Market cap | $276.74M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$2.31 |
| 52-week high | $7.75 |
| 52-week low | $1.46 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | — |
| Return on equity (ROE) | -545.85% |
| Debt-to-equity | — |
| Average volume | 278,525 |
| Shares outstanding | 62.75M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 48 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is CAMP4 THERAPEUTICS CORPORATION's current P/E ratio?
- CAMP4 THERAPEUTICS CORPORATION (CAMP) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is CAMP4 THERAPEUTICS CORPORATION's market capitalisation?
- CAMP4 THERAPEUTICS CORPORATION's market cap is $276.74M based on our latest snapshot. See how it ranks by market cap →
- What is CAMP's 52-week range?
- Over the past 52 weeks, CAMP has traded between $1.46 and $7.75. What does the 52-week range mean? →
- How volatile is CAMP4 THERAPEUTICS CORPORATION compared to the market?
- CAMP4 THERAPEUTICS CORPORATION has a beta of —. What does beta measure? →
- Does CAMP4 THERAPEUTICS CORPORATION pay a dividend?
- CAMP4 THERAPEUTICS CORPORATION does not currently pay a dividend according to our latest data.
- What exchange is CAMP listed on?
- CAMP is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is CAMP4 THERAPEUTICS CORPORATION in?
- CAMP4 THERAPEUTICS CORPORATION is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →